Treatment of Persistent Diarrhea

Initial Assessment and Management

The American College of Physicians recommends assessing the degree of dehydration as the first step in management, as fluid replacement is the cornerstone of treatment for all patients with diarrhea 1
Determine if warning signs are present (high fever, bloody stools, severe vomiting, obvious dehydration) that would necessitate immediate medical attention 1

The Infectious Diseases Society of America recommends administering oral rehydration solution (ORS) for mild to moderate dehydration 2, 1
For severe dehydration, provide intravenous fluids such as lactated Ringer's or normal saline until pulse, perfusion, and mental status normalize 2
Replace ongoing losses with ORS until diarrhea resolves 2
The American Academy of Pediatrics recommends continuing breast-feeding throughout the diarrheal episode for children 2
Consider lactose-free or lactose-reduced formulas for bottle-fed infants with persistent diarrhea 1

The American Gastroenterological Association recommends starting loperamide at an initial dose of 4 mg followed by 2 mg every 4 hours or after every unformed stool (not to exceed 16 mg/day) 3, 4, 1
If mild to moderate diarrhea persists for more than 24 hours, increase loperamide dose to 2 mg every 2 hours 3, 4
Avoid loperamide in children under 18 years of age 2

Discontinue loperamide if diarrhea persists for more than 48 hours on high-dose therapy 3, 4
Start second-line agents such as subcutaneous octreotide (100-150 μg starting dose, with dose escalation as needed) 3, 4, 5
Consider other second-line agents such as oral budesonide or tincture of opium 3, 4
For persistent diarrhea in cancer patients, low doses of morphine concentrate may be more cost-effective than tincture of opium 5, 6

The National Comprehensive Cancer Network recommends empiric antibiotics are not routinely recommended for persistent diarrhea unless specific indications are present 2, 7
Consider antibiotics for patients with fever, bloody diarrhea, or recent international travel 2, 7
Avoid antibiotics in infections attributed to STEC O157 and other Shiga toxin 2-producing E. coli 2, 7
For immunocompromised patients, consider more aggressive management with earlier consideration of antimicrobial therapy 1, 7
In cancer patients receiving chemotherapy or radiation therapy, octreotide may be beneficial for persistent diarrhea 3, 8, 5

No improvement within 48 hours of self-treatment, or if symptoms worsen 1
Development of warning signs: severe vomiting, dehydration, persistent fever, abdominal distension, or blood in stools 1

Neglecting rehydration while focusing solely on antimotility agents 2, 1
Overuse of empiric antibiotics in uncomplicated diarrhea, which can lead to antimicrobial resistance 7
Continuing loperamide beyond 48 hours if ineffective 3, 4